Revolutions Medical Corp., makers of the RevVac safety syringe, RevDisplay and Rev3D MRI Technology, yesterday offered a summary of milestones achieved in 2009, together with a look at what to expect in 2010.

In spite of the weak overall economy, Revolutions Medical was successful in raising capital and meeting all of its short term operational goals, beginning a transition from a product development company to a manufacturing and distribution company of important medical devices. Below is a summary of key 2009 achievements.

• The company ascended to Over-the-Counter Bulletin Board status. • They acquired 100% of Clear Image Acquisition Corporation, the developer of their advanced MRI software technology. • They invested approximately $3 million toward RevColor and Rev 3D MRI product development, while investing another $3 million toward development of the RevVac Safety Syringe. • They received FDA 510K clearance for the RevVac Safety Syringe. • They launched the initial steps of the RevVac manufacturing process for

...

Alzheimer’s disease (AD) is a devastating neuro-degenerative disease that affects people over the age of 60. The onset of the disease is often so gradual and the early signs are so mild that they are often mistaken as common traits of ageing.  Early detection of the disease is significant as many of the available treatment options are most effective in the early stages. However, there is no such detection test available currently although some are under trial.  The situation may change completely if Bayer (BAYRY) accomplishes its objective. The company recently decided to go ahead with the development of florbetaben to support the proper diagnosis of AD.  At the recently held 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA), Bayer announced the enrollment of the first patient in a phase III clinical trial to evaluate the efficacy and safety of ...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Friday Nov 27, 2009

DrStockPick.com Stock Report!

**************************************************************

Cavitation Technologies, Inc. (OTC BB: CVAT.OB) has filed three new PCT patent applications to protect our intellectual property worldwide. The patents are for Flow-Through Cavitation Assisted Rapid Modification of Crude Oil, Modification of Beverage Fluids, and Method for Cavitation Assisted Refining, Degumming and Dewaxing of Oil and Fat, for its Nano Cavitation Technologies. Furthermore, a research report has been issued on the Company by Grass Roots Research and Distribution Inc., Wall Street’s leading independent research firm, with a “BUY”

...

Dr Stock Pick HOT News & Alerts!

_______________________________________

FREE Daily Stock Alerts From DrStockPick.com

_______________________________________

Tuesday November 17, 2009

DrStockPick.com Stock Report!

**************************************************************

Power3 Medical Products, Inc. (OTCBB: PWRM), a leader in neurodegenerative disease and cancer biomarkers and diagnostic tests, announces further international recognition of validity as the company’s President and CSO, Dr. Ira Goldknopf, will deliver an invited Keynote address and chair a session on “Biomarkers and Diagnostics in Personalized Medicine (Track 6-4),” at the BIT Life Sciences 2nd International Congress and Expo of Molecular Diagnostics in Beijing, China, November 19-21, 2009. The Theme of the meeting is “New Leadership of

...